v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII
- PMID: 1682217
- DOI: 10.1101/gad.5.11.2033
v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII
Abstract
The v-erbA oncoprotein represents a retrovirus-transduced oncogenic version of the thyroid hormone (T3/T4) receptor c-erbA (type alpha). It contributes to virus-induced erythroleukemia by efficiently arresting differentiation of red cell progenitors and by suppressing transcription of erythrocyte-specific genes. Here, we show that v-erbA and c-erbA bind directly to sequences within the promoter of the erythrocyte-specific carbonic anhydrase II (CAII), a gene whose transcription is efficiently suppressed by v-erbA. This erbA-binding site confers thyroid hormone responsiveness to a heterologous promoter in transient expression experiments and is a target for efficient down-regulation of CAII transcription by the v-erbA oncoprotein. In stably transformed erythroblasts coexpressing the v-erbA oncoprotein and the c-erbA/T3 receptor at an approximately equimolar ratio, c-erbA activity is dominant over v-erbA. T3 efficiently induced erythroid differentiation in these cells, thus overcoming the v-erbA-mediated differentiation arrest. Likewise, T3 activated CAII transcription as well as transient expression of a T3-responsive reporter gene containing the CAII-specific erbA-binding site. The c-erbA-dependent activation of this CAII reporter construct could only be suppressed by very high amounts of v-erbA. Our results suggest that overexpression of v-erbA is required for its function as an oncoprotein.
Similar articles
-
c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.Oncogene. 1994 Oct;9(10):2853-67. Oncogene. 1994. PMID: 7916146
-
Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.EMBO J. 1992 Sep;11(9):3355-65. doi: 10.1002/j.1460-2075.1992.tb05414.x. EMBO J. 1992. PMID: 1354613 Free PMC article.
-
Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.Oncogene. 1992 Feb;7(2):217-27. Oncogene. 1992. PMID: 1347914
-
The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?Cancer Surv. 1992;14:169-80. Cancer Surv. 1992. PMID: 1358441 Review.
-
ErbA: tumor suppressor turned oncogene?FASEB J. 1993 Jul;7(10):904-9. doi: 10.1096/fasebj.7.10.8102105. FASEB J. 1993. PMID: 8102105 Review.
Cited by
-
Large-scale analysis by SAGE reveals new mechanisms of v-erbA oncogene action.BMC Genomics. 2007 Oct 26;8:390. doi: 10.1186/1471-2164-8-390. BMC Genomics. 2007. PMID: 17961265 Free PMC article.
-
A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily.Mol Cell Biol. 1994 Oct;14(10):7025-35. doi: 10.1128/mcb.14.10.7025-7035.1994. Mol Cell Biol. 1994. PMID: 7935418 Free PMC article.
-
Rat adrenal chromaffin cells are neonatal CO2 sensors.J Neurosci. 2005 Jul 13;25(28):6631-40. doi: 10.1523/JNEUROSCI.1139-05.2005. J Neurosci. 2005. PMID: 16014724 Free PMC article.
-
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.EMBO J. 1998 Dec 15;17(24):7382-94. doi: 10.1093/emboj/17.24.7382. EMBO J. 1998. PMID: 9857194 Free PMC article.
-
The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.EMBO J. 1998 Aug 3;17(15):4291-303. doi: 10.1093/emboj/17.15.4291. EMBO J. 1998. PMID: 9687498 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases